Synthesis and cytotoxic activity of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidine derivatives

被引:39
作者
Angel Vilchis-Reyes, Miguel [1 ]
Zentella, Alejandro [2 ]
Angel Martinez-Urbina, Miguel [1 ]
Guzman, Angel [1 ]
Vargas, Omar [2 ]
Ramirez Apan, Maria Teresa [1 ]
Ventura Gallegos, Jose Luis [2 ]
Diaz, Eduardo [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico
关键词
Imidazo[1,2-a]pyridine; Quinoline; Bioisosteric replacement; CDK; Apoptosis; SELECTIVE CLASS; INHIBITORS; POTENT; SAR;
D O I
10.1016/j.ejmech.2009.10.002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidines derivatives were synthesized using a convenient synthetic route. We evaluate the isosteric replacement of methyl groups in 4-(2-methylimidazo[1,2-a]pyridin-3-yl)-N-p-tolylpyrimidin-2-amine (compound 1) by trifluoromethyl groups and the isosteric substitution of the 2-methylimidazo[1,2-a]pyridin-3-yl scaffold by quinolin-4-yl or quinolin-3-yl moieties. The replacement of hydrogen by fluorine does not affect notably the cytotoxic activity and CDK inhibitor activity in this series. Quinolin-4-yl-substituted compound, 8, presents cytotoxic activity and is most effective and selective against CDK1/CycA than against CDK2/CycB. Compound 11, which has a quinolin-3-yl moiety is CDK inhibitor but presents null cytotoxic activity. Quinolin-4-yl-substituted compounds constitute a new lead of cytotoxic and CDK inhibitor compounds from which more compelling and selective inhibitors can be designed. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 17 条
  • [1] A novel class of orally active non-peptide bradykinin B2 receptor antagonists.: 3.: Discovering bioisosteres of the imidazo[1,2-α]pyridine moiety
    Abe, Y
    Kayakiri, H
    Satoh, S
    Inoue, T
    Sawada, Y
    Inamura, N
    Asano, M
    Aramori, I
    Hatori, C
    Sawai, H
    Oku, T
    Tanaka, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) : 4062 - 4079
  • [2] Imidazo[1,2-a]pyridines:: A potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation
    Anderson, M
    Beattie, JF
    Breault, GA
    Breed, J
    Byth, KF
    Culshaw, JD
    Ellston, RPA
    Green, S
    Minshull, CA
    Norman, RA
    Pauptit, RA
    Stanway, J
    Thomas, AP
    Jewsbury, PJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) : 3021 - 3026
  • [3] IRAK-4 inhibitors.: Part III:: A series of imidazo[1,2-a] pyridines
    Buckley, George M.
    Fosbeary, Richard
    Fraser, Joanne L.
    Gowers, Lewis
    Higueruelo, Alicia P.
    James, Lynwen A.
    Jenkins, Kerry
    Mack, Stephen R.
    Morgan, Trevor
    Parry, David M.
    Pitt, William R.
    Rausch, Oliver
    Richard, Marianna D.
    Sabin, Verity
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3656 - 3660
  • [4] Imidazo[1,2-α]pyridines.: Part 2:: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors
    Byth, KF
    Culshaw, JD
    Green, S
    Oakes, SE
    Thomas, AP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2245 - 2248
  • [5] Substituted 3-imidazo[1,2-a]pyridin-3-yl-4-(1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3
    Engler, TA
    Henry, JR
    Malhotra, S
    Cunningham, B
    Furness, K
    Brozinick, J
    Burkholder, TP
    Clay, MP
    Clayton, J
    Diefenbacher, C
    Hawkins, E
    Iversen, PW
    Li, YH
    Lindstrom, TD
    Marquart, AL
    McLean, J
    Mendel, D
    Misener, E
    Briere, D
    O'Toole, JC
    Porter, WJ
    Queener, S
    Reel, JK
    Owens, RA
    Brier, RA
    Eessalu, TE
    Wagner, JR
    Campbell, RM
    Vaughn, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (16) : 3934 - 3937
  • [6] Synthesis and SAR of 2-(4-fluorophenyl)-3-pyrimidin-4-ylimidazo[1,2-a]pyridine derivatives as anticoccidial agents
    Feng, Dennis
    Fisher, Michael
    Liang, Gui-Bai
    Qian, Xiaoxia
    Brown, Chris
    Gurnett, Anne
    Leavitt, Penny Sue
    Liberator, Paul A.
    Mathew, John
    Misura, Andrew
    Samaras, Samantha
    Tamas, Tamas
    Schmatz, Dennis M.
    Wyvratt, Matthew
    Biftu, Tesfaye
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 5978 - 5981
  • [7] CARBON-FLUORINE BOND IN COMPOUNDS OF BIOLOGICAL INTEREST
    GOLDMAN, P
    [J]. SCIENCE, 1969, 164 (3884) : 1123 - &
  • [8] Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum
    Gompel, M
    Leost, M
    Joffe, EBD
    Puricelli, L
    Franco, LH
    Palermo, J
    Meijer, L
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) : 1703 - 1707
  • [9] Synthesis and antiviral activity of novel erythrofuranosyl imidazo[1,2-a]pyridine C-nucleosides constructed via palladium coupling of iodoimidazo[1,2-a]pyridines and dihydrofuran
    Gudmundsson, KS
    Williams, JD
    Drach, JC
    Townsend, LB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) : 1449 - 1455
  • [10] Harrison TS, 2005, CNS DRUGS, V19, P65